Centurion Corporation Ltd (CCL), a leading provider of purpose-built worker accommodation (PBWA) and student accommodation across Singapore, Malaysia, Australia, and the UK, has demonstrated robust growth momentum in its 1H26 results. The company operates a diversified portfolio of accommodation assets serving both migrant workers and students across multiple markets.
Strong Revenue Growth Driven by Strategic Acquisitions
CCL’s revenue performance has been particularly impressive, with first-half 2026 revenue surging 31% year-on-year to S$184.9 million, marking the company’s strongest growth since the first half of 2022. This exceptional performance was primarily driven by a series of strategic acquisitions and asset enhancement initiatives across key markets.
The revenue acceleration reflects several major acquisitions that have significantly expanded CCL’s capacity. The company acquired an additional 55% stake in the 8,006-bed Westlite Mandai Purpose-Built Workers’ Accommodation (PBWA) facility, representing 19% of Singapore’s capacity. In Malaysia, CCL acquired the 7,083-bed Harum Megah PBWA, adding 20% to the country’s capacity. The Australian market saw the addition of the 732-bed EPIISOD Macquarie Park facility, which boosted Australia’s PBSA capacity by 82%.
Beyond acquisitions, ongoing asset enhancement initiatives have contributed substantially to growth. These projects added 5,460 beds, representing a 13% increase in Singapore capacity through expansions at Westlite Toh Guan and Westlite Mandai PBWA facilities, which are currently in the occupancy ramp-up phase.
Market Dynamics Signal Continued Demand
A significant positive development for CCL came through securing a three-year lease extension from JTC for the 1,224-bed Westlite Tuas Avenue 2 quick build dormitory, with options for an additional 3.5-year extension. This extension indicates a shortage of worker dormitories in Singapore, particularly given the progress of major construction projects including Changi Terminal 5, Marina Bay Sands Integrated Resort, healthcare facilities, and Cross Island Line construction.
Investment Outlook and Guidance
Phillip Securities Research maintains a BUY recommendation with an upgraded target price of S$1.94, increased from the previous S$1.85. The revised valuation incorporates CCL’s 7,000-bed Kranji Close PBWA project and improved quick build dormitory valuations. CCL has provided forward revenue guidance of S$190 million for the second half of 2026, representing 22% year-on-year growth, with total beds expected to grow at a 5% compound annual growth rate through 2028.
Frequently Asked Questions
Q: What drove Centurion Corporation's strong revenue growth in 1H26?
A: Revenue surged 31% year-on-year to S$184.9 million, driven by strategic acquisitions including additional stakes in Westlite Mandai PBWA, acquiring Harum Megah PBWA in Malaysia, and the EPIISOD Macquarie Park facility in Australia, plus asset enhancement initiatives adding 5,460 beds.
Q: What is Phillip Securities Research's recommendation and target price for CCL?
A: Phillip Securities Research maintains a BUY rating with a target price of S$1.94, raised from the previous S$1.85, based on a sum-of-the-parts valuation model.
Q: Why is the lease extension for Westlite Tuas Avenue 2 significant?
A: The three-year lease extension with options for an additional 3.5 years indicates a shortage of worker dormitories in Singapore, supported by major construction projects including Changi T5, Marina Bay Sands Integrated Resort, healthcare facilities, and Cross Island Line construction.
Q: What growth guidance has CCL provided?
A: CCL provided forward revenue guidance of S$190 million for 2H26, representing 22% year-on-year growth, with total beds expected to grow at a 5% compound annual growth rate from 85,528 beds in June 2026 to 94,944 beds in 2028.
Q: How did acquisitions impact CCL's capacity across different markets?
A: The acquisitions significantly expanded capacity: Westlite Mandai represents 19% of Singapore capacity, Harum Megah adds 20% to Malaysia capacity, and EPIISOD Macquarie Park increased Australia PBSA capacity by 82%.
Q: What were CCL's 1H26 results relative to expectations?
A: CCL's 1H26 revenue and adjusted PATMI were within expectations, representing 47% and 49% respectively of full-year 2026 forecasts, though adjusted PATMI declined 16% year-on-year to S$48.8 million due to higher profits attributable to non-controlling interests.
This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst.
Disclaimer
These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products.
Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance.
Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries.
The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries.
Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned.
This advertisement has not been reviewed by the Monetary Authority of Singapore.
